BU Research Oversight

The BU Research Oversight Committee oversees:

  • IRB - Human Subject Research
  • IACUC - Institututional Animal Care
  • IBC - Institutional Biosafety Committee

BU-IRB Office & Mailing Address: Centennial Hall 212

ORSP Director - Ms. Sadie Hauck, 570-389-4208
IRB Chair - Dr. Jeffrey Leitzel, 570-389-4322
IRB Administrator - Ms. Christine Orlando, 570-389-4322

IRB Human Subjects

The cornerstone of protection for human research participants is an independent Institutional Review Board (IRB), which reviews research activities at an institution with the focus of protecting the rights and welfare of human subjects recruited to participate in those research activities.

Bloomsburg University's IRB is authorized to approve, require changes, or disapprove all research activities that it reviews.

Officials in the research office may disapprove a project that has been approved by an IRB, however, they may not approve research that has been disapproved by the IRB. The first priority of Bloomsburg's Human Subjects Review Board is to protect the participants in all research carried out at the university.

The Human Subjects Review Board considers the following points when reviewing submission:

First, subjects must be given sufficient information on which to decide whether or not to participate, including the research procedures, their purposes, risks and anticipated benefits, alternative procedures (where therapy is involved), and a statement offering the subject the opportunity to ask questions and to withdraw at any time from the research.

Second, subjects must be able to comprehend the information that is given to them. The presentation of information must be adapted to the subject's capacity to understand it.

Finally, consent to participate must be voluntarily given. The conditions under which an agreement to participate is made must be free from coercion and undue influence. IRBs should be especially sensitive to these factors when particularly vulnerable subjects are involved.


Please note that all research must be approved by the Human Subjects Review Board before it can be performed on campus.  This includes all requests from other schools both within the PASSHE System and those not within the PASSHE system.  Anyone asked to be part of research or survey should ask for the approval letter.  If they do not have an approval letter please ask them to contact Dr. Jeffrey Leitzel, 570-389-4322.


    The Bloomsburg University Institutional Animal Care and Use Committee (IACUC) has oversight of all non-human animal research conducted on campus (see PRP 3995). The members of the IACUC review all proposed research activities involving non-human animals, with a focus on protecting the health and welfare of the non-human subjects.

    The IACUC is authorized to approve, require changes to, or disapprove all proposed research activities that it reviews. In addition, the IACUC is authorized to suspend any research activities that are in violation of previously approved protocols.

    In addition to the review of research protocols involving the use of non-human animals, the members of the IACUC also conduct an internal program review and research facilities inspection on a semi-annual basis.

    Contact Information

    Questions can be directed to Dr. Eric Stouffer at estouffe@bloomu.edu


    Under the NIH guidelines, the University, its Institutional Biosafety Committee (IBC), and the Principal Investigator are assigned major roles in assuring that work with recombinant DNA is performed as safely as possible, and in ways that eliminate or reduce potential exposure of personnel and environment.

    The Principal Investigator has an obligation to be closely familiar with health and safety guidelines applicable to their work and to adhere to them. The University has ultimate responsibility and is guided in providing such assurance by the IBC.


    The mission of the Institutional Biosafety Committee is:

    To ensure that all recombinant DNA research activities at Bloomsburg University of Pennsylvania comply with Department of Health and Human Services, National Institutes of Health Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines).

    To ensure that protocols of all research at the University which uses or produces biohazardous organisms or materials requiring Biological Safety Level 2 or higher containment, including but not limited to recombinant DNA, are reviewed and found to protect personnel, environmental, and public safety.

    To ensure that protocols of all research at the University, which use or produces genetically modified plants (through the use of recombinant DNA) are reviewed and found to protect personal, environmental, and public safety.

    All research involving recombinant DNA, human and/or animal pathogens, and genetically modified plants must be approved by the BU IBC before research can be initiated. The BU IBC meets as needed to fulfill its mission. Membership of the BU IBC consists of both faculty and external reviewers with expertise covering recombinant DNA technology, molecular biology, microbiology, infectious disease, animal care, and botany.

    All questions should be directed to Dr. Karl Henry at khenry@bloomu.edu


    An Anonymous Tipline link is provided below to allow individuals to report biosafety non-compliance issues occurring at the University or to report problems
    with the BU IBC.


    Institutional Research Oversight Resources